BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22585541)

  • 1. Determination of nicotine absorption from multiple tobacco products and nicotine gum.
    Digard H; Proctor C; Kulasekaran A; Malmqvist U; Richter A
    Nicotine Tob Res; 2013 Jan; 15(1):255-61. PubMed ID: 22585541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study.
    Lunell E; Lunell M
    Nicotine Tob Res; 2005 Jun; 7(3):397-403. PubMed ID: 16085507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.
    Stein JS; Wilson AG; Koffarnus MN; Judd MC; Bickel WK
    Psychopharmacology (Berl); 2017 Jan; 234(2):245-254. PubMed ID: 27730273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and behaviors of snus consumption in Sweden.
    Digard H; Errington G; Richter A; McAdam K
    Nicotine Tob Res; 2009 Oct; 11(10):1175-81. PubMed ID: 19687306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
    Andersson G; Björnberg G; Curvall M
    J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
    Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine Content in Swedish-Type Snus Sold in Norway From 2005 to 2020.
    Vedøy TF; Lund KE
    Nicotine Tob Res; 2022 Jun; 24(7):1130-1133. PubMed ID: 35022786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical analysis of snus products from the United States and northern Europe.
    Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
    PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Use Topography and Nicotine Pharmacokinetics Among Loose and Portioned Smokeless Tobacco Users.
    Nighbor T; Meredith S; Salazar E; Cartagena C; Koszowski B; Pickworth WB; Hull LC
    Nicotine Tob Res; 2023 Mar; 25(4):624-630. PubMed ID: 35965261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014.
    Cheng YC; Rostron BL; Day HR; Stanton CA; Hull LC; Persoskie A; Travers MJ; Taylor K; Conway KP; Ambrose BK; Borek N
    Am J Public Health; 2017 Sep; 107(9):1508-1514. PubMed ID: 28727534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Intensity Sweeteners in Alternative Tobacco Products.
    Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
    Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enamel staining with e-cigarettes, tobacco heating products and modern oral nicotine products compared with cigarettes and snus: An in vitro study.
    Dalrymple A; Bean EJ; Badrock TC; Weidman RA; Thissen J; Coburn S; Murphy J
    Am J Dent; 2021 Feb; 34(1):3-9. PubMed ID: 33544982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
    Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
    J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
    Caldwell B; Burgess C; Crane J
    Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Dependence across Different Types of Nicotine Containing Products and Coffee.
    Fagerstrom K
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30061507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
    Lunell E; Fagerström K; Hughes J; Pendrill R
    Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
    Azzopardi D; Liu C; Murphy J
    Drug Chem Toxicol; 2022 Sep; 45(5):2246-2254. PubMed ID: 34034614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.